Homocysteine, folic acid and B-group vitamins in obstetrics and gynaecology (Q35089478)

6 August 2017

1 reference

title

Homocysteine, folic acid and B-group vitamins in obstetrics and gynaecology (English)

1 reference

6 August 2017

0 references

1 reference

de la Calle M

1

1 reference

6 August 2017

Usandizaga R

2

1 reference

6 August 2017

Sancha M

3

1 reference

6 August 2017

Magdaleno F

4

1 reference

6 August 2017

Herranz A

5

1 reference

6 August 2017

Cabrillo E

6

1 reference

6 August 2017

language of work or name

1 reference

1 April 2003

1 reference

European Journal of Obstetrics Gynecology and Reproductive Biology

6 August 2017

published in

1 reference

6 August 2017

volume

107

1 reference

6 August 2017

issue

2

1 reference

6 August 2017

page(s)

125-134

1 reference

[Homocysteine and pregnancy]

6 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0301-2115%2802%2900305-6

7 January 2021

The placenta in maternal hyperhomocysteinaemia

1 reference

https://api.crossref.org/works/10.1016%2FS0301-2115%2802%2900305-6

7 January 2021

Plasma homocyst(e)ine concentrations in pregnant and nonpregnant women with controlled folate intake

1 reference

https://api.crossref.org/works/10.1016%2FS0301-2115%2802%2900305-6

7 January 2021

Changes in homocysteine levels during normal pregnancy

1 reference

https://api.crossref.org/works/10.1016%2FS0301-2115%2802%2900305-6

7 January 2021

Total homocyst(e)ine in plasma and amniotic fluid of pregnant women

1 reference

https://api.crossref.org/works/10.1016%2FS0301-2115%2802%2900305-6

7 January 2021

Maternal and fetal levels of methionine and homocysteine in early human pregnancy

1 reference

https://api.crossref.org/works/10.1016%2FS0301-2115%2802%2900305-6

7 January 2021

Is homocysteine a biomarker for identifying women at risk of complications and adverse pregnancy outcomes?

1 reference

https://api.crossref.org/works/10.1016%2FS0301-2115%2802%2900305-6

7 January 2021

Vitamin deficiencies and neural tube defects

1 reference

https://api.crossref.org/works/10.1016%2FS0301-2115%2802%2900305-6

7 January 2021

THE ROLE OF FOLIC ACID IN PREGNANCY; WITH PARTICULAR REFERENCE TO ANAEMIA, ABRUPTION AND ABORTION

1 reference

https://api.crossref.org/works/10.1016%2FS0301-2115%2802%2900305-6

7 January 2021

Possible prevention of neural-tube defects by periconceptional vitamin supplementation

1 reference

https://api.crossref.org/works/10.1016%2FS0301-2115%2802%2900305-6

7 January 2021

Double-blind randomised controlled trial of folate treatment before conception to prevent recurrence of neural-tube defects

1 reference

https://api.crossref.org/works/10.1016%2FS0301-2115%2802%2900305-6

7 January 2021

Homocysteine metabolism in pregnancies complicated by neural-tube defects

1 reference

https://api.crossref.org/works/10.1016%2FS0301-2115%2802%2900305-6

7 January 2021

Prevention of the First Occurrence of Neural-Tube Defects by Periconceptional Vitamin Supplementation

1 reference

https://api.crossref.org/works/10.1016%2FS0301-2115%2802%2900305-6

7 January 2021

Folic acid, folate and homocysteine: human intervention studies

1 reference

https://api.crossref.org/works/10.1016%2FS0301-2115%2802%2900305-6

7 January 2021

Maternal hyperhomocysteinemia: a risk factor for neural-tube defects?

1 reference

https://api.crossref.org/works/10.1016%2FS0301-2115%2802%2900305-6

7 January 2021

Amniotic fluid B12 and folate levels associated with neural tube defects

1 reference

https://api.crossref.org/works/10.1016%2FS0301-2115%2802%2900305-6

7 January 2021

Amniotic fluid B12, calcium, and lead levels associated with neural tube defects

1 reference

https://api.crossref.org/works/10.1016%2FS0301-2115%2802%2900305-6

7 January 2021

Folate intake in Europe: recommended, actual and desired intake

1 reference

https://api.crossref.org/works/10.1016%2FS0301-2115%2802%2900305-6

7 January 2021

Neural tube defects and elevated homocysteine levels in amniotic fluid

1 reference

https://api.crossref.org/works/10.1016%2FS0301-2115%2802%2900305-6

7 January 2021

Homocysteine metabolism in pregnancies complicated by neural tube defects

1 reference

https://api.crossref.org/works/10.1016%2FS0301-2115%2802%2900305-6

7 January 2021

Prevention of neural tube defects by and toxicity of L-homocysteine in cultured postimplantation rat embryos

1 reference

https://api.crossref.org/works/10.1016%2FS0301-2115%2802%2900305-6

7 January 2021

Amniotic fluid homocysteine levels, 5,10-methylenetetrahydrafolate reductase genotypes, and neural tube closure sites

1 reference

https://api.crossref.org/works/10.1016%2FS0301-2115%2802%2900305-6

7 January 2021

Role of amniotic fluid homocysteine level and of fetal 5, 10-methylenetetrahydrafolate reductase genotype in the etiology of neural tube defects

1 reference

https://api.crossref.org/works/10.1016%2FS0301-2115%2802%2900305-6

7 January 2021

Folic acid supplementation and neural tube defects

1 reference

https://api.crossref.org/works/10.1016%2FS0301-2115%2802%2900305-6

7 January 2021

A common variant in methionine synthase reductase combined with low cobalamin (vitamin B12) increases risk for spina bifida

1 reference

https://api.crossref.org/works/10.1016%2FS0301-2115%2802%2900305-6

7 January 2021

Homocysteine and folate levels as risk factors for recurrent early pregnancy loss

1 reference

https://api.crossref.org/works/10.1016%2FS0301-2115%2802%2900305-6

7 January 2021

Methylenetetrahydrofolate reductase polymorphism affects the change in homocysteine and folate concentrations resulting from low dose folic acid supplementation in women with unexplained recurrent miscarriages

1 reference

https://api.crossref.org/works/10.1016%2FS0301-2115%2802%2900305-6

7 January 2021

The role of vitamins in the pathogenesis and treatment of hyperhomocyst(e)inaemia

1 reference

https://api.crossref.org/works/10.1016%2FS0301-2115%2802%2900305-6

7 January 2021

Homocysteine increases as folate decreases in plasma of healthy men during short-term dietary folate and methyl group restriction

1 reference

https://api.crossref.org/works/10.1016%2FS0301-2115%2802%2900305-6

7 January 2021

Determinants and vitamin responsiveness of intermediate hyperhomocysteinemia (> or = 40 micromol/liter). The Hordaland Homocysteine Study

1 reference

https://api.crossref.org/works/10.1016%2FS0301-2115%2802%2900305-6

7 January 2021

Plasma homocysteine, a risk factor for cardiovascular disease, is lowered by physiological doses of folic acid

1 reference

https://api.crossref.org/works/10.1016%2FS0301-2115%2802%2900305-6

7 January 2021

Vitamin supplementation reduces blood homocysteine levels: a controlled trial in patients with venous thrombosis and healthy volunteers

1 reference

https://api.crossref.org/works/10.1016%2FS0301-2115%2802%2900305-6

7 January 2021

Serum levels of folate and cobalamin in women with recurrent spontaneous abortion

1 reference

https://api.crossref.org/works/10.1016%2FS0301-2115%2802%2900305-6

7 January 2021

Low-dose folic acid supplementation decreases plasma homocysteine concentrations: a randomized trial

1 reference

https://api.crossref.org/works/10.1016%2FS0301-2115%2802%2900305-6

7 January 2021

Further experience of vitamin supplementation for prevention of neural tube defect recurrences

1 reference

https://api.crossref.org/works/10.1016%2FS0301-2115%2802%2900305-6

7 January 2021

Effects of folic acid and vitamin B6 supplementation on women with hyperhomocysteinemia and a history of preeclampsia or fetal growth restriction

1 reference

https://api.crossref.org/works/10.1016%2FS0301-2115%2802%2900305-6

7 January 2021

Nonsyndromic orofacial clefts: association with maternal hyperhomocysteinemia

1 reference

https://api.crossref.org/works/10.1016%2FS0301-2115%2802%2900305-6

7 January 2021

Folic acid for the prevention of congenital anomalies

1 reference

https://api.crossref.org/works/10.1016%2FS0301-2115%2802%2900305-6

7 January 2021

Early pregnancy wastage: relationship between chorionic vascularization and embryonic development

1 reference

https://api.crossref.org/works/10.1016%2FS0301-2115%2802%2900305-6

7 January 2021

Maternal homocysteine and chorionic vascularization in recurrent early pregnancy loss

1 reference

https://api.crossref.org/works/10.1016%2FS0301-2115%2802%2900305-6

7 January 2021

Presence of the French Canadian deletion in a French patient with familial hypercholesterolemia

1 reference

https://api.crossref.org/works/10.1016%2FS0301-2115%2802%2900305-6

7 January 2021

Hyperhomocysteinaemia and recurrent spontaneous abortion or abruptio placentae

1 reference

https://api.crossref.org/works/10.1016%2FS0301-2115%2802%2900305-6

7 January 2021

A woman with five consecutive fetal deaths: Case report and retrospective analysis of hyperhomocysteinemia prevalence in 100 consecutive women with recurrent miscarriages

1 reference

https://api.crossref.org/works/10.1016%2FS0301-2115%2802%2900305-6

7 January 2021

Hyperhomocysteinemia: a risk factor in women with unexplained recurrent early pregnancy loss

1 reference

https://api.crossref.org/works/10.1016%2FS0301-2115%2802%2900305-6

7 January 2021

Recurrent miscarriage. II: Clinical associations, causes, and management

1 reference

https://api.crossref.org/works/10.1016%2FS0301-2115%2802%2900305-6

7 January 2021

Plasma total homocysteine, pregnancy complications, and adverse pregnancy outcomes: the Hordaland Homocysteine study

1 reference

https://api.crossref.org/works/10.1016%2FS0301-2115%2802%2900305-6

7 January 2021

Homocysteine--a pathophysiological cornerstone in obstetrical and gynaecological disorders?

1 reference

https://api.crossref.org/works/10.1016%2FS0301-2115%2802%2900305-6

7 January 2021

Underlying disorders associated with severe early-onset preeclampsia

1 reference

https://api.crossref.org/works/10.1016%2FS0301-2115%2802%2900305-6

7 January 2021

Increased frequency of genetic thrombophilia in women with complications of pregnancy

1 reference

https://api.crossref.org/works/10.1016%2FS0301-2115%2802%2900305-6

7 January 2021

Hyperhomocysteinaemia and protein S deficiency in complicated pregnancies

1 reference

https://api.crossref.org/works/10.1016%2FS0301-2115%2802%2900305-6

7 January 2021

Thrombophilias and adverse outcomes of pregnancy--what should a clinician do?

1 reference

https://api.crossref.org/works/10.1016%2FS0301-2115%2802%2900305-6

7 January 2021

Elevated homocyst(e)ine levels with preeclampsia

1 reference

https://api.crossref.org/works/10.1016%2FS0301-2115%2802%2900305-6

7 January 2021

Second-trimester plasma homocysteine levels and pregnancy-induced hypertension, preeclampsia, and intrauterine growth restriction

1 reference

https://api.crossref.org/works/10.1016%2FS0301-2115%2802%2900305-6

7 January 2021

Dietary and serum folate: their influence on the outcome of pregnancy

1 reference

https://api.crossref.org/works/10.1016%2FS0301-2115%2802%2900305-6

7 January 2021

Plasma homocysteine concentration is increased in preeclampsia and is associated with evidence of endothelial activation

1 reference

https://api.crossref.org/works/10.1016%2FS0301-2115%2802%2900305-6

7 January 2021

Plasma homocysteine levels elevated and inversely related to insulin sensitivity in preeclampsia.

1 reference

https://api.crossref.org/works/10.1016%2FS0301-2115%2802%2900305-6

7 January 2021

Homocysteine and cardiovascular disease

1 reference

https://api.crossref.org/works/10.1016%2FS0301-2115%2802%2900305-6

7 January 2021

Hyperhomocyst(e)inemia as a risk factor for occlusive vascular disease

1 reference

https://api.crossref.org/works/10.1016%2FS0301-2115%2802%2900305-6

7 January 2021

Major lifestyle determinants of plasma total homocysteine distribution: the Hordaland Homocysteine Study

1 reference

https://api.crossref.org/works/10.1016%2FS0301-2115%2802%2900305-6

7 January 2021

Changes of plasma total homocysteine levels during the menstrual cycle

1 reference

https://api.crossref.org/works/10.1016%2FS0301-2115%2802%2900305-6

7 January 2021

Total homocysteine and estrogen status indicators in the Third National Health and Nutrition Examination Survey

1 reference

https://api.crossref.org/works/10.1016%2FS0301-2115%2802%2900305-6

7 January 2021

Plasma homocysteine and menopausal status

1 reference

https://api.crossref.org/works/10.1016%2FS0301-2115%2802%2900305-6

7 January 2021

Influence of menopausal status in homocysteine plasma levels

1 reference

https://api.crossref.org/works/10.1016%2FS0301-2115%2802%2900305-6

7 January 2021

Homocysteine and risk of cardiovascular disease among postmenopausal women

1 reference

https://api.crossref.org/works/10.1016%2FS0301-2115%2802%2900305-6

7 January 2021

Increased plasma homocysteine after menopause

1 reference

https://api.crossref.org/works/10.1016%2FS0301-2115%2802%2900305-6

7 January 2021

Postmenopausal hormone replacement, risk estimators for coronary artery disease and cardiovascular protection

1 reference

https://api.crossref.org/works/10.1016%2FS0301-2115%2802%2900305-6

7 January 2021

Hormone replacement therapy and ischaemic heart disease among postmenopausal women

1 reference

https://api.crossref.org/works/10.1016%2FS0301-2115%2802%2900305-6

7 January 2021

Hormone replacement therapy in postmenopausal women with specific risk factors for coronary artery disease

1 reference

https://api.crossref.org/works/10.1016%2FS0301-2115%2802%2900305-6

7 January 2021

The effect of sequential three-monthly hormone replacement therapy on several cardiovascular risk estimators in postmenopausal women.

1 reference

https://api.crossref.org/works/10.1016%2FS0301-2115%2802%2900305-6

7 January 2021

Hormone replacement therapy and plasma homocysteine levels

1 reference

https://api.crossref.org/works/10.1016%2FS0301-2115%2802%2900305-6

7 January 2021

Cardiovascular disease risk and hormone replacement therapy (HRT): a review based on randomised, controlled studies in postmenopausal women

1 reference

https://api.crossref.org/works/10.1016%2FS0301-2115%2802%2900305-6

7 January 2021

Hormone replacement therapy may reduce high serum homocysteine in postmenopausal women

1 reference

https://api.crossref.org/works/10.1016%2FS0301-2115%2802%2900305-6

7 January 2021

A randomized controlled study of the effects of 17Beta-estradiol-dydrogesterone on plasma homocysteine in postmenopausal women

1 reference

https://api.crossref.org/works/10.1016%2FS0301-2115%2802%2900305-6

7 January 2021

Postmenopausal oral 17beta-estradiol continuously combined with dydrogesterone reduces fasting serum homocysteine levels

1 reference

https://api.crossref.org/works/10.1016%2FS0301-2115%2802%2900305-6

7 January 2021

Plasma Homocysteine in Women Taking Hormone Replacement Therapy: The Postmenopausal Estrogen/Progestin Interventions (PEPI) Trial

1 reference

https://api.crossref.org/works/10.1016%2FS0301-2115%2802%2900305-6

7 January 2021

Effects of hormonal replacement therapy on lipid and haemostatic factors in post-menopausal ESRD patients

1 reference

https://api.crossref.org/works/10.1016%2FS0301-2115%2802%2900305-6

7 January 2021

Failure of the combination of sequential oral and transdermal estradiol plus norethisterone acetate to affect plasma homocysteine levels

1 reference

https://api.crossref.org/works/10.1016%2FS0301-2115%2802%2900305-6

7 January 2021

Hormone replacement therapy and cobalamin status in elderly women

1 reference

https://api.crossref.org/works/10.1016%2FS0301-2115%2802%2900305-6

7 January 2021

Randomized, double-blind, placebo-controlled study of the effects of raloxifene and conjugated equine estrogen on plasma homocysteine levels in healthy postmenopausal women

1 reference

https://api.crossref.org/works/10.1016%2FS0301-2115%2802%2900305-6

7 January 2021

Serum total homocysteine concentrations in the third National Health and Nutrition Examination Survey (1991-1994): population reference ranges and contribution of vitamin status to high serum concentrations

1 reference

https://api.crossref.org/works/10.1016%2FS0301-2115%2802%2900305-6

7 January 2021

The effect of folic acid fortification on plasma folate and total homocysteine concentrations

1 reference

https://api.crossref.org/works/10.1016%2FS0301-2115%2802%2900305-6

7 January 2021

Homocysteine and vascular disease

1 reference

https://api.crossref.org/works/10.1016%2FS0301-2115%2802%2900305-6

7 January 2021

Oral estrogen improves serum lipids, homocysteine and fibrinolysis in elderly men.

1 reference

https://api.crossref.org/works/10.1016%2FS0301-2115%2802%2900305-6

7 January 2021

Effects of sex steroids on plasma total homocysteine levels: a study in transsexual males and females

1 reference

https://api.crossref.org/works/10.1016%2FS0301-2115%2802%2900305-6

7 January 2021

Effects of sub-50 oral contraceptives on homocysteine metabolism: a preliminary study

1 reference

https://api.crossref.org/works/10.1016%2FS0301-2115%2802%2900305-6

7 January 2021

Oral contraceptives did not affect biochemical folate indexes and homocysteine concentrations in adolescent females

1 reference

https://api.crossref.org/works/10.1016%2FS0301-2115%2802%2900305-6

7 January 2021

Correlates of total plasma homocysteine: folic acid, copper, and cervical dysplasia

1 reference

https://api.crossref.org/works/10.1016%2FS0301-2115%2802%2900305-6

7 January 2021

Case-control study of plasma folate, homocysteine, vitamin B(12), and cysteine as markers of cervical dysplasia

1 reference

https://api.crossref.org/works/10.1016%2FS0301-2115%2802%2900305-6

7 January 2021

Effect of total plasma homocysteine on cervical dysplasia risk

1 reference

https://api.crossref.org/works/10.1016%2FS0301-2115%2802%2900305-6

7 January 2021

10.1016/S0301-2115(02)00305-6

Identifiers

DOI

1 reference

6 August 2017

1 reference